# A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors

> **NCT06341114** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Bio-Thera Solutions** · enrollment: 112 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** BAT8008 injection
- **DRUG:** BAT1308 injection

## Key facts

- **NCT ID:** NCT06341114
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-12
- **Primary completion:** 2026-04-03
- **Final completion:** 2026-07-28
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06341114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06341114, "A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06341114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*